AtriCure Launched CryoSPHERE+ Cryoablation Probe To Reduce Freeze Times By 25% Vs. AtriCure's Legacy CryoSPHERE Device. The Product Is Currently In An Extended Limited Launch Period In US, With Full Launch Expected By The End Of Q2
AtriCure Launched CryoSPHERE+ Cryoablation Probe To Reduce Freeze Times By 25% Vs. AtriCure's Legacy CryoSPHERE Device. The Product Is Currently In An Extended Limited Launch Period In US, With Full Launch Expected By The End Of Q2
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.